サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1594925

獣医腫瘍学の世界市場

Veterinary Oncology

出版日
ページ情報
英文 93 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
獣医腫瘍学の世界市場
出版日: 2024年11月22日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 93 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

獣医腫瘍学の世界市場は2030年までに7億2,780万米ドルに達する見込み

2023年に3億5,820万米ドルと推定される獣医腫瘍学の世界市場は、分析期間2023～2030年にCAGR 10.7%で成長し、2030年には7億2,780万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである化学療法は、CAGR 11.8％を記録し、分析期間終了時には2億4,600万米ドルに達すると予測されています。放射線分野の成長率は、分析期間中CAGR 9.4％と推定されます。

米国市場は9,340万米ドルと推定、中国はCAGR14.0%で成長すると予測

米国の獣医腫瘍学市場は、2023年に9,340万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに1億6,800万米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは14.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ7.2%と8.8%と予測されています。欧州では、ドイツがCAGR約8.3%で成長すると予測されています。

世界の獣医腫瘍学市場- 主要動向と促進要因まとめ

獣医腫瘍学とは何か、なぜ動物医療において非常に重要なのか？

獣医腫瘍学は、動物のがんの診断、治療、管理に焦点を当てた獣医学の専門分野です。化学療法、放射線療法、免疫療法、外科手術、標的療法など様々な治療法があり、ペットや家畜、さらにはエキゾチックアニマルのリンパ腫、肥満細胞腫、骨肉腫、黒色腫など、様々な種類のがんを治療するために考案されています。獣医腫瘍学は、早期診断、高度な治療オプション、継続的なケアを通じて、動物の寿命を延ばし、痛みを和らげ、がん患者の生活の質を向上させることを目指しています。

獣医腫瘍学の重要性は、犬や猫などのコンパニオンアニマルだけでなく、家畜や野生動物の間でも増加しているがんの有病率に対応し、動物に包括的ながん治療を提供する能力にあります。ヘルスケア、栄養、生活環境の改善によりペットが長生きするようになり、がんのような加齢に関連する疾患が一般的になってきています。獣医腫瘍学は、専門的な診断ツール、個別化された治療計画、緩和ケアを提供し、ペットの飼い主が複雑ながん症例をより効果的に管理できるよう支援します。動物福祉や飼い主と動物との間の感情的な絆に対する意識の高まりとともに、獣医腫瘍学は、動物に対するより高度で思いやりのあるケアへの幅広い動向と一致し、現代の獣医療に不可欠な要素となっています。

技術の進歩は獣医腫瘍学市場をどのように形成しているか？

技術の進歩は、獣医腫瘍学の診断、治療、緩和能力を著しく向上させ、この分野全体の技術革新を促進しています。主な進展の一つは、コンピュータ断層撮影（CT）、磁気共鳴画像法（MRI）、陽電子放射断層撮影（PET）、超音波などの高度な画像診断技術の台頭です。これらの画像診断によって、腫瘍の大きさ、位置、進行度に関する詳細な洞察が得られるため、獣医師はがんの正確な診断、治療計画の立案、反応モニタリングが可能となります。画像誘導による生検や手術の精度も向上し、組織の損傷を最小限に抑え、腫瘍摘出が成功する可能性が高まっています。

標的療法と免疫療法の進歩は、動物のがん治療に新たな選択肢を提供し、獣医腫瘍学を一変させました。標的療法は、健康な組織に影響を与えることなく、特定のがん細胞を攻撃するように設計された薬剤を使用し、有効性を向上させ、副作用を軽減します。チロシンキナーゼ阻害剤（TKI）やモノクローナル抗体は、特に肥満細胞腫やリンパ腫のような症状に対して、獣医腫瘍学で使用されることが増えている標的治療の一例です。動物の免疫系を刺激してがん細胞を認識・破壊させる免疫療法も、動物の様々なタイプの腫瘍に対する有望な治療法として台頭してきています。犬用のメラノーマ・ワクチンのようなワクチンは、攻撃性の高いがんの治療に免疫療法を用いる上で大きなブレークスルーとなります。

遺伝子検査や分子診断を含む精密医療の導入により、獣医師はより個別化された治療計画を立てることができるようになりました。腫瘍の遺伝子構成を分析することで、獣医がん専門医は治療決定の指針となる特定の変異を特定することができ、治療効果を高め、生存率を向上させることができます。放射線治療の統合も進んでおり、定位放射線治療（SRT）や強度変調放射線治療（IMRT）が使用され、周囲の健康な組織へのダメージを最小限に抑える高線量の標的治療が提供されています。これらの技術革新は、獣医腫瘍学で利用可能な治療の選択肢を広げるだけでなく、より個別化され、正確で、効果的ながん治療を動物に提供するという、より広範な動向とも一致しています。

さまざまな動物種における獣医腫瘍学の新たな応用例とは？

獣医腫瘍学は、コンパニオンアニマル、非コンパニオンアニマルの両方において、専門的ながん治療の必要性により、様々な動物種で用途が拡大しています。犬や猫などのコンパニオンアニマルでは、リンパ腫、肥満細胞腫、骨肉腫、乳腺腫瘍などに腫瘍学的治療が一般的に用いられています。化学療法は依然として広く用いられている治療法であり、がんの種類や病期によっては手術や放射線療法と併用されることも多いです。小動物の治療では、腹腔鏡下腫瘍摘出術のような侵襲の少ない手術手技の使用も増えており、回復までの時間が短縮され、治療成績も向上しています。

馬や家畜を含む大動物では、扁平上皮がん、サルコイド、リンパ腫などの疾患の管理に獣医腫瘍学が適用されます。解剖学的、生理学的な差異により治療法は異なるが、放射線や凍結手術などの高度な治療法が馬の腫瘍治療に採用され、生存率やQOLを向上させています。大動物用に調整された化学療法プロトコールは、支持療法と組み合わされ、家畜、特に貴重な繁殖動物に影響を及ぼす特定のタイプのがんを管理するための獣医腫瘍学の実践の一部でもあります。

エキゾチックアニマルや野生動物では、獣医腫瘍学は動物園の動物、鳥類、爬虫類、その他人間の管理下にある種のがんを管理するために不可欠となっています。これらの動物は、解剖学的構造、行動、免疫反応の違いから、がん治療において独特の課題があり、専門的な診断・治療アプローチが必要となります。例えば、電気化学療法（化学療法と電気パルスの組み合わせ）のような革新的なアプローチは、小型哺乳類やエキゾチックペットの腫瘍治療に使用され、効果的で低侵襲な選択肢を提供しています。様々な動物種で獣医腫瘍学の応用が拡大していることは、動物ヘルスケアの進歩とがん動物の予後改善における獣医腫瘍学の重要な役割を裏付けています。

獣医腫瘍学市場の成長の促進要因は？

獣医腫瘍学市場の成長は、ペット飼育の増加、ペットの健康に対する意識の高まり、がん治療技術の進歩など、いくつかの要因によってもたらされます。主な成長要因の一つは、世界のペット飼育数の増加であり、ペットを家族の一員と考え、高度なヘルスケアを求める家庭が増えています。ペットの平均寿命が延びるにつれて、コンパニオンアニマルのがんの発生率も上昇し、専門的な腫瘍学サービスに対する需要が高まっています。診断、治療、緩和支援など、包括的ながんケアに投資しようというペットの飼い主の意欲が、獣医腫瘍学サービスの需要に拍車をかけています。

がんの症状に対する意識の高まりと高度な診断ツールの利用可能性も市場の成長に寄与しています。獣医師はがんを早期に発見できるようになり、より効果的な治療計画と予後の改善が可能になりました。腫瘍学に特化したサービスを提供する動物病院やクリニックの増加と動物病院紹介センターの増加により、ペットのがん治療へのアクセスが向上しています。さらに、獣医腫瘍学における遠隔医療の利用は、専門家である腫瘍医の活動範囲を拡大し、遠隔地からの診察、治療計画、フォローアップ治療を可能にし、十分なサービスを受けていない地域における専門的治療へのアクセスを向上させています。

標的治療、精密医療、低侵襲手術などの技術の進歩は、獣医腫瘍学で利用できる治療法の選択肢を大幅に広げ、成功率を向上させ、副作用を減少させました。獣医がん研究に対する規制当局の支援や資金援助も新薬や治療法の開発に貢献し、この分野の技術革新を後押ししています。高品質な動物ヘルスケアに対する需要が拡大し続ける中、獣医腫瘍学市場は、ペットの健康増進、がん治療に対する意識の向上、がん患者の個別ケアへの関心の高まりといった世界の動向に支えられ、堅調な拡大が見込まれています。

セグメント

治療法（化学療法、放射線療法、免疫療法、外科手術、その他の治療法）;がんの種類（リンパ腫、肥満細胞がん、乳腺・扁平上皮がん、その他のがんの種類）;動物の種類（イヌ、ネコ）

調査対象企業の例（全42件）

  • Accuray, Inc.
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health
  • Elekta AB
  • Karyopharm Therapeutics, Inc.
  • Merck Animal Health
  • Torigen Pharmaceuticals
  • Varian
  • Virbac SA
  • Vivesto AB

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP23026

Global Veterinary Oncology Market to Reach US$727.8 Million by 2030

The global market for Veterinary Oncology estimated at US$358.2 Million in the year 2023, is expected to reach US$727.8 Million by 2030, growing at a CAGR of 10.7% over the analysis period 2023-2030. Chemotherapy, one of the segments analyzed in the report, is expected to record a 11.8% CAGR and reach US$246.0 Million by the end of the analysis period. Growth in the Radiology segment is estimated at 9.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$93.4 Million While China is Forecast to Grow at 14.0% CAGR

The Veterinary Oncology market in the U.S. is estimated at US$93.4 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$168.0 Million by the year 2030 trailing a CAGR of 14.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.2% and 8.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.

Global Veterinary Oncology Market - Key Trends & Drivers Summarized

What Is Veterinary Oncology, and Why Is It So Crucial in Animal Healthcare?

Veterinary Oncology is a specialized field of veterinary medicine focused on diagnosing, treating, and managing cancer in animals. It encompasses various treatment modalities such as chemotherapy, radiation therapy, immunotherapy, surgery, and targeted therapy, designed to treat different types of cancers, including lymphomas, mast cell tumors, osteosarcomas, and melanomas in pets, livestock, and even exotic animals. Veterinary oncology aims to extend the lifespan of animals, alleviate pain, and improve the quality of life for cancer patients through early diagnosis, advanced treatment options, and ongoing care.

The importance of veterinary oncology lies in its ability to provide comprehensive cancer care for animals, addressing an increasing prevalence of cancer among companion animals such as dogs and cats, as well as livestock and wildlife. As pets are living longer due to improved healthcare, nutrition, and living conditions, age-related conditions like cancer have become more common. Veterinary oncology offers specialized diagnostic tools, personalized treatment plans, and palliative care, helping pet owners manage complex cancer cases more effectively. With growing awareness of animal welfare and the emotional bond between pet owners and their animals, veterinary oncology has become a vital component of modern veterinary medicine, aligning with broader trends toward more advanced and compassionate care for animals.

How Are Technological Advancements Shaping the Veterinary Oncology Market?

Technological advancements have significantly enhanced the diagnostic, therapeutic, and palliative capabilities of Veterinary Oncology, driving innovation across the field. One of the major developments is the rise of advanced diagnostic imaging technologies, such as computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and ultrasound. These imaging modalities provide detailed insights into tumor size, location, and progression, enabling veterinarians to accurately diagnose cancer, plan treatments, and monitor responses. Imaging-guided biopsies and surgeries have also improved precision, minimizing tissue damage and increasing the likelihood of successful tumor removal.

Advancements in targeted therapies and immunotherapies have transformed veterinary oncology, offering new options for treating cancers in animals. Targeted therapies use drugs designed to attack specific cancer cells without affecting healthy tissues, improving efficacy and reducing side effects. Tyrosine kinase inhibitors (TKIs) and monoclonal antibodies are examples of targeted treatments that are increasingly being used in veterinary oncology, especially for conditions like mast cell tumors and lymphomas. Immunotherapies, which stimulate the animal’s immune system to recognize and destroy cancer cells, are also emerging as promising treatments for various types of tumors in animals. Vaccines, such as the melanoma vaccine for dogs, represent a significant breakthrough in using immunotherapy to manage aggressive cancers.

The adoption of precision medicine, including genetic testing and molecular diagnostics, has enabled veterinarians to develop more personalized treatment plans. By analyzing the genetic makeup of tumors, veterinary oncologists can identify specific mutations that guide treatment decisions, increasing the effectiveness of therapies and improving survival rates. The integration of radiation therapy has also advanced, with the use of stereotactic radiation therapy (SRT) and intensity-modulated radiation therapy (IMRT), offering high-dose, targeted treatments that minimize damage to surrounding healthy tissues. These technological innovations not only expand the treatment options available in veterinary oncology but also align with broader trends toward more personalized, precise, and effective cancer care for animals.

What Are the Emerging Applications of Veterinary Oncology Across Different Animal Types?

Veterinary Oncology is finding expanding applications across a variety of animal species, driven by the need for specialized cancer care in both companion and non-companion animals. In companion animals, such as dogs and cats, oncology treatments are commonly used for lymphomas, mast cell tumors, osteosarcomas, and mammary gland tumors. Chemotherapy remains a widely used treatment option, often in combination with surgery or radiation therapy, depending on the type and stage of the cancer. The use of less invasive surgical techniques, such as laparoscopic tumor removal, has also increased in treating small animals, offering quicker recovery times and improved outcomes.

In large animals, including horses and livestock, veterinary oncology is applied to manage conditions such as squamous cell carcinoma, sarcoids, and lymphoma. While the treatment options may differ due to anatomical and physiological variations, advanced therapies like radiation and cryosurgery are employed to treat tumors in horses, improving survival rates and quality of life. Chemotherapy protocols tailored for large animals, combined with supportive care, are also part of veterinary oncology practice for managing certain types of cancers in livestock, particularly those affecting valuable breeding animals.

In exotic animals and wildlife, veterinary oncology has become essential for managing cancers in zoo animals, birds, reptiles, and other species under human care. These animals present unique challenges in cancer treatment due to differences in anatomy, behavior, and immune response, requiring specialized diagnostic and therapeutic approaches. For example, innovative approaches like electrochemotherapy (a combination of chemotherapy and electrical pulses) are used to treat tumors in small mammals and exotic pets, offering an effective and minimally invasive option. The expanding applications of veterinary oncology across diverse animal types underscore its critical role in advancing animal healthcare and improving outcomes for animals with cancer.

What Drives Growth in the Veterinary Oncology Market?

The growth in the Veterinary Oncology market is driven by several factors, including increasing pet ownership, rising awareness of pet health, and advancements in cancer treatment technologies. One of the primary growth drivers is the global rise in pet ownership, with more households viewing pets as family members and seeking advanced healthcare options for them. As the average lifespan of pets increases, the incidence of cancer among companion animals has also risen, creating greater demand for specialized oncology services. Pet owners’ willingness to invest in comprehensive cancer care, including diagnostics, treatment, and palliative support, has fueled the demand for veterinary oncology services.

The growing awareness of cancer symptoms and the availability of advanced diagnostic tools have also contributed to market growth. Veterinarians are now able to detect cancers earlier, allowing for more effective treatment plans and better prognoses. The increasing number of veterinary clinics and hospitals offering specialized oncology services, coupled with the rise of veterinary referral centers, has improved access to cancer care for pets. Additionally, the use of telemedicine in veterinary oncology has expanded the reach of expert oncologists, enabling remote consultations, treatment planning, and follow-up care, which enhances access to specialized treatments in underserved areas.

Technological advancements, including targeted therapies, precision medicine, and minimally invasive procedures, have significantly expanded the treatment options available in veterinary oncology, improving success rates and reducing side effects. Regulatory support and funding for veterinary cancer research have also contributed to the development of new drugs and treatments, driving innovation in the field. As the demand for high-quality animal healthcare continues to grow, the Veterinary Oncology market is poised for robust expansion, supported by global trends toward better pet health, increasing awareness of cancer treatments, and a growing focus on personalized care for animals with cancer.

SCOPE OF STUDY:

The report analyzes the Veterinary Oncology market in terms of US$ Thousand by the following Animal Type; Cancer Type; Therapy, and Geographic Regions/Countries:

Segments:

Therapy (Chemotherapy, Radiology, Immunotherapy, Surgery, Other Therapies); Cancer Type (Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer, Other Cancer Types); Animal Type (Canine, Feline)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Accuray, Inc.
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health
  • Elekta AB
  • Karyopharm Therapeutics, Inc.
  • Merck Animal Health
  • Torigen Pharmaceuticals
  • Varian
  • Virbac SA
  • Vivesto AB

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Veterinary Oncology - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Cancer in Animals Drives Veterinary Oncology Market
    • Expanding Use of Chemotherapy Sets the Stage for Oncology Market Expansion
    • Case Overview: Demand for Immunotherapy Enhances Veterinary Oncology Market
    • Innovations in Tumor-Specific Diagnostics Generate New Opportunities
    • Growing Use of Radiation Therapy Sustains Veterinary Oncology Demand
    • Push for Early Cancer Detection Drives Oncology Market
    • Expanding Use of Monoclonal Antibodies Drives Veterinary Oncology Demand
    • Focus on Quality of Life in Pets Bodes Well for Veterinary Oncology
    • Innovations in Drug Delivery Systems Propel Veterinary Oncology Market
    • Increasing Use of Biomarkers in Diagnosis Drives Oncology Demand
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Veterinary Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Veterinary Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Veterinary Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Radiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Radiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Radiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Chemotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Immunotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Immunotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Immunotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Other Therapies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Canine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Canine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Canine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Feline by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Feline by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Feline by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Lymphoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Lymphoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Lymphoma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Mast Cell Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Mast Cell Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 30: World 16-Year Perspective for Mast Cell Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Mammary & Squamous Cell Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Mammary & Squamous Cell Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 33: World 16-Year Perspective for Mammary & Squamous Cell Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 36: World 16-Year Perspective for Other Cancer Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 37: World Veterinary Oncology Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • JAPAN
    • Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • CHINA
    • Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: China 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • EUROPE
    • Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Veterinary Oncology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Veterinary Oncology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Veterinary Oncology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • FRANCE
    • Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: France 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • GERMANY
    • Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Spain 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Spain 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Spain 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Russia 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Russia 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Russia 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of Europe 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of Europe 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Rest of Europe 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Oncology by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Veterinary Oncology by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Veterinary Oncology by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Asia-Pacific 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Australia 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Australia 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Australia 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • INDIA
    • Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 170: India Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: India 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: India 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: India 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: South Korea 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: South Korea 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: South Korea 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Veterinary Oncology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Veterinary Oncology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Veterinary Oncology by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Latin America 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Latin America 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Argentina 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 214: Argentina 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 217: Argentina 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 220: Brazil 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 223: Brazil 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 226: Brazil 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 229: Mexico 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 232: Mexico 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 235: Mexico 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 238: Rest of Latin America 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 241: Rest of Latin America 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 244: Rest of Latin America 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Veterinary Oncology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Veterinary Oncology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Veterinary Oncology by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 253: Middle East 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 256: Middle East 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 259: Iran 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 262: Iran 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 265: Iran 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 268: Israel 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 271: Israel 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 274: Israel 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 277: Saudi Arabia 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 280: Saudi Arabia 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 283: Saudi Arabia 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 286: UAE 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 289: UAE 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 292: UAE 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 295: Rest of Middle East 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 298: Rest of Middle East 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 301: Rest of Middle East 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • AFRICA
    • Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 304: Africa 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 307: Africa 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 310: Africa 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030

IV. COMPETITION